Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.390
-0.010 (-0.71%)
At close: May 9, 2025, 4:00 PM
1.370
-0.020 (-1.43%)
After-hours: May 9, 2025, 7:26 PM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $277.72 million as of May 9, 2025. Its market cap has decreased by -15.79% in one year.
Market Cap
277.72M
Enterprise Value
242.29M
1-Year Change
-15.79%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $277.72M, a decrease of -87.87%. That is a compound annual growth rate of -41.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 279.71M | 25.33% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.85B |
| Johnson & Johnson | 371.67B |
| UnitedHealth Group | 359.09B |
| AbbVie | 331.06B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.50B |
| AstraZeneca | 221.83B |
| Novartis AG | 220.92B |